Moritoki, Yuki

Publishing since 2003 (Junior)

Has published 32 publications in 8 years

Number of publications published per year by Moritoki, Yuki. (Source : PubMed)

Distribution of publications types for Moritoki, Yuki. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME. Murine models of autoimmune cholangitis. Curr. Opin. Gastroenterol. 2010
Moritoki Y, Lian ZX, Lindor K, Tuscano J, Tsuneyama K, Zhang W, Ueno Y, Dunn R, Kehry M, Coppel RL, Mackay IR, Gershwin ME. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology 2009;50;6
Lafdil F, Wang H, Park O, Zhang W, Moritoki Y, Yin S, Fu XY, Gershwin ME, Lian ZX, Gao B. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 2009;137;6
Yoshida K, Yang GX, Zhang W, Tsuda M, Tsuneyama K, Moritoki Y, Ansari AA, Okazaki K, Lian ZX, Coppel RL, Mackay IR, Gershwin ME. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 2009;50;5
Zhang W, Moritoki Y, Tsuneyama K, Yang GX, Ilan Y, Lian ZX, Gershwin ME. Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis. Clin. Exp. Immunol. 2009;157;3
Kawai T, Hosoya N, Moritoki Y, Kajiyama Y, Watanabe M, Takai A, Selmi C, Gershwin ME, Miyakawa H, Kikuchi K. Autoantibody IgG subclasses to recombinant antigens and the role of bacterial stimuli in primary biliary cirrhosis. Hepatol. Res. 2009;39;9
Kikuchi K, Hsu W, Hosoya N, Moritoki Y, Kajiyama Y, Kawai T, Takai A, Hayami E, Selmi C, Gershwin ME, Miyakawa H. Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis. Hepatol. Res. 2009;39;5
Wakabayashi K, Yoshida K, Leung PS, Moritoki Y, Yang GX, Tsuneyama K, Lian ZX, Hibi T, Ansari AA, Wicker LS, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME. Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin. Exp. Immunol. 2009;155;3
Moritoki Y, Zhang W, Tsuneyama K, Yoshida K, Wakabayashi K, Yang GX, Bowlus C, Ridgway WM, Ueno Y, Ansari AA, Coppel RL, Mackay IR, Flavell RA, Gershwin ME, Lian ZX. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 2009;136;3
Kenny TP, Shu SA, Moritoki Y, Keen CL, Gershwin ME. Cocoa flavanols and procyanidins can modulate the lipopolysaccharide activation of polymorphonuclear cells in vitro. J Med Food 2009;12;1

[ See timeline ] [ See all publications ]

h=14

means that Moritoki, Yuki has 14 papers cited a least 14 times - methodology

Key figures

32 pub in 8 years
4.0 publications/year
best year 2009 with 11 pub
h-index 14 with 32 pub
h-ratio : 43 %

See Timeline

Ranking

It's me !

Click here if you are
Moritoki, Yuki.

Most frequent Journals

Hepatology (9x)
Hepatol. Res. (6x)
Clin. Exp. Immunol. (4x)
J. Autoimmun. (3x)
Liver Int. (2x)

Main affiliation

aDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan bDivision of Rheumatology and Clinical Immunology, School of Medicine, University of California, Davis, California, USA cTeikyo University Mizonokuchi Hospital, Mizonokuchi, Takatsu-ku, Kawasaki, Japan dDivision of Immunology, Rheumatology and Allergy, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Latest co-workers

Ansari AA Chuang YH Coppel RL Fukushima K Gershwin ME Hsu W Kanno N Kikuchi K Lan RY Lian ZX Mackay IR Ridgway WM Shimosegawa T Shu SA Tsuneyama K Ueno Y Wakabayashi K Yang GX Yoshida K Zhang W

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.